Low Serum miR-19a Expression as a Novel Poor Prognostic Indicator in Multiple Myeloma

Multiple myeloma (MM) is the second most common hematologic malignancy characterized by the clonal expansion of plasma cells. Despite continuing advances, novel biomarkers are needed for diagnosis and prognosis of MM. In this study we characterized the diagnostic and prognostic potential of circulat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Cancer
Hlavní autoři: Hao, Mu, Zang, Meirong, Wendlandt, Erik, Xu, Yan, An, Gang, Gong, Dasen, Li, Fei, Qi, Fang, Zhang, Yanru, Yang, Ye, Zhan, Fenghuang, Qiu, Lugui
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4382914/
https://ncbi.nlm.nih.gov/pubmed/25220540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.29199
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky